SCHEMBL18273213

SCHEMBL18273213

c1ccc2c(c1)oc1c(-c3nc(-c4cccc5c4oc4ccccc45)c4oc5ccccc5c4n3)cccc12

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALOX5 P09917 2/20 0.44
▸ MAPT P10636 4/20 0.42
▸ KDM4E B2RXH2 4/20 0.42
▸ ALDH1A1 P00352 4/20 0.42
▸ MEN1 O00255 1/20 0.42
▸ KMT2A Q03164 1/20 0.42
▸ POLB P06746 1/20 0.41
▸ PIM1 P11309 1/20 0.41
▸ CSNK2A2 P19784 1/20 0.41
▸ CSNK2B P67870 1/20 0.41
▸ PIM3 Q86V86 1/20 0.41
▸ PIM2 Q9P1W9 1/20 0.41
▸ PIK3CD O00329 1/20 0.41
▸ PIK3CB P42338 1/20 0.41
▸ PRKDC P78527 1/20 0.41
▸ NPSR1 Q6W5P4 1/20 0.41
▸ TSHR P16473 2/20 0.39
▸ HPGD P15428 1/20 0.39
▸ MAPK1 P28482 2/20 0.39
▸ SMN1; SMN2 Q16637 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20024791 0.88 ALOX5 (0.52) ALOX5MAPTKDM4EALDH1A1MEN1
SCHEMBL25017757 0.88 MAPT (0.47) ALOX5MAPTKDM4EALDH1A1MEN1
SCHEMBL25017050 0.88 MAPT (0.47) ALOX5MAPTKDM4EALDH1A1MEN1
SCHEMBL25016709 0.88 MAPT (0.47) ALOX5MAPTKDM4EALDH1A1MEN1
SCHEMBL23610614 0.87 PIM1 (0.47) ALOX5MAPTALDH1A1MEN1KMT2A
SCHEMBL21148345 0.87 ALOX5 (0.47) ALOX5MAPTKDM4EALDH1A1MEN1
SCHEMBL23610606 0.86 PIM1 (0.47) ALOX5MAPTKDM4EALDH1A1MEN1
SCHEMBL24056363 0.86 PIM1 (0.47) ALOX5MAPTKDM4EALDH1A1MEN1
SCHEMBL25016401 0.86 MAPT (0.46) ALOX5MAPTKDM4EALDH1A1MEN1
SCHEMBL18273207 0.86 MAPT (0.45) ALOX5MAPTKDM4EALDH1A1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4237506-B1 ORGANIC ELECTROLUMINESCENT DEVICE MERCK PATENT GMBH (DE) 2024-07-17 — — EP disclosed
WO-2022090108-A1 ORGANIC ELECTROLUMINESCENT DEVICE MERCK PATENT GMBH (DE) 2022-05-05 — — WO disclosed
US-20160351826-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG SDI CO., LTD. (KR) 2016-12-01 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160351826-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNE2 ALOX5 1855/4885MAPT 1162/4885KDM4E 3527/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback